# FDA Inspection 1221633 - Joel Abrahm Pearlman, M.D. - October 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/joel-abrahm-pearlman-md/55237d2b-57dc-4849-b667-d2fb5bae7d34
Source feed: FDA_Inspections

> FDA Inspection 1221633 for Joel Abrahm Pearlman, M.D. on October 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221633
- Company Name: Joel Abrahm Pearlman, M.D.
- Inspection Date: 2023-10-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 780585 - 2012-05-04](https://www.keypedia.com/records/fda_inspections/joel-abrahm-pearlman-md/a13d79c6-b62e-46ac-979d-3da1a9ebc00e)

Company: https://www.keypedia.com/companies/joel-abrahm-pearlman-md/35ea2009-d8d4-4a95-8f0b-2fc36ab4ab4c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c